{"id":"butetamate","rwe":[],"tags":[{"label":"butetamate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"butethamate","offLabel":[],"synonyms":["butethamate citrate","phenethylaminecitrate","butethamate","butetamate"],"timeline":[],"brandName":"Butethamate","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"butetamate","explanation":"Imagine butethamate as a key that fits into a lock in the body. When it binds to this lock, it can help to turn off or slow down certain processes that are involved in a disease. However, the exact details of how butethamate works are still being studied and are not yet fully understood.","oneSentence":"Butethamate is thought to work by interacting with a specific target in the body, although the exact mechanism is currently unknown.","technicalDetail":"Butethamate is a small molecule that binds to a specific target, although the identity of this target is currently unknown. Its mechanism of action is thought to involve modulation of a biological pathway, although the precise details of this process are still being investigated."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/445","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BUTETAMATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:05:28.342608","biosimilars":[],"competitors":[],"genericName":"butetamate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"004309","UNII":"2VO6TC90PU","CHEBI":"CHEBI:135086","INN_ID":"2296","RXNORM":"156762","UMLSCUI":"C0771148","ChEMBL_ID":"CHEMBL1623049","KEGG_DRUG":"D07597","PUBCHEM_CID":"27368","SNOMEDCT_US":"703407002","SECONDARY_CAS_RN":"84473-65-4","MESH_SUPPLEMENTAL_RECORD_UI":"C006843"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Butethamate, also known as BUTETAMATE, is a small molecule drug in the butetamate class. Its original development is attributed to an unknown entity, and its current ownership is also unclear. The target of butetamate is currently unknown, and it has not been approved by the FDA for any indications. As a result, there is limited information available on its commercial status, pharmacokinetics, or safety profile. Further research is needed to fully understand the properties and potential applications of butetamate.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}